BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 30779712)

  • 1. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
    Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.
    Dong Z; Zhang G; Qu M; Gimple RC; Wu Q; Qiu Z; Prager BC; Wang X; Kim LJY; Morton AR; Dixit D; Zhou W; Huang H; Li B; Zhu Z; Bao S; Mack SC; Chavez L; Kay SA; Rich JN
    Cancer Discov; 2019 Nov; 9(11):1556-1573. PubMed ID: 31455674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.
    Fang X; Zhou W; Wu Q; Huang Z; Shi Y; Yang K; Chen C; Xie Q; Mack SC; Wang X; Carcaboso AM; Sloan AE; Ouyang G; McLendon RE; Bian XW; Rich JN; Bao S
    J Exp Med; 2017 Jan; 214(1):245-267. PubMed ID: 27923907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3.
    Hou X; Yang L; Wang K; Zhou Y; Li Q; Kong F; Liu X; He J
    Cancer Med; 2021 Jan; 10(1):350-364. PubMed ID: 33280236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma.
    Mack SC; Singh I; Wang X; Hirsch R; Wu Q; Villagomez R; Bernatchez JA; Zhu Z; Gimple RC; Kim LJY; Morton A; Lai S; Qiu Z; Prager BC; Bertrand KC; Mah C; Zhou W; Lee C; Barnett GH; Vogelbaum MA; Sloan AE; Chavez L; Bao S; Scacheri PC; Siqueira-Neto JL; Lin CY; Rich JN
    J Exp Med; 2019 May; 216(5):1071-1090. PubMed ID: 30948495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation.
    von Eyss B; Maaskola J; Memczak S; Möllmann K; Schuetz A; Loddenkemper C; Tanh MD; Otto A; Muegge K; Heinemann U; Rajewsky N; Ziebold U
    EMBO J; 2012 Feb; 31(4):972-85. PubMed ID: 22157815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
    Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
    Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
    Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
    Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
    Gallo M; Coutinho FJ; Vanner RJ; Gayden T; Mack SC; Murison A; Remke M; Li R; Takayama N; Desai K; Lee L; Lan X; Park NI; Barsyte-Lovejoy D; Smil D; Sturm D; Kushida MM; Head R; Cusimano MD; Bernstein M; Clarke ID; Dick JE; Pfister SM; Rich JN; Arrowsmith CH; Taylor MD; Jabado N; Bazett-Jones DP; Lupien M; Dirks PB
    Cancer Cell; 2015 Dec; 28(6):715-729. PubMed ID: 26626085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
    Wang X; Huang Z; Wu Q; Prager BC; Mack SC; Yang K; Kim LJY; Gimple RC; Shi Y; Lai S; Xie Q; Miller TE; Hubert CG; Song A; Dong Z; Zhou W; Fang X; Zhu Z; Mahadev V; Bao S; Rich JN
    Cancer Res; 2017 Sep; 77(18):4947-4960. PubMed ID: 28729418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage display targeting identifies EYA1 as a regulator of glioblastoma stem cell maintenance and proliferation.
    Kim J; She C; Potez M; Huang P; Wu Q; Prager BC; Qiu Z; Bao S; Rich JN; Liu JKC
    Stem Cells; 2021 Jul; 39(7):853-865. PubMed ID: 33594762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression.
    Huang H; Yu X; Han X; Hao J; Zhao J; Bebek G; Bao S; Prayson RA; Khalil AM; Jankowsky E; Yu JS
    Cell Rep; 2021 Jan; 34(1):108522. PubMed ID: 33406417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.